
    
      This study will be a phase â…¢ open label interventional case series. Patients with
      retinoblastoma will be randomized to receive chemotherapy with or without periocular
      injections of carboplatin at a dose of 20mg/2 ml. Patients will receive carboplatin
      periocular on a monthly basis for a total duration of therapy of 6 months. Patients will be
      followed for 24 months .
    
  